OptiBiotix Health PLC Investor presentation
October 09 2020 - 9:00AM
RNS Non-Regulatory
TIDMOPTI
OptiBiotix Health PLC
09 October 2020
Opti B i otix Health plc
( "Opti Bi o t ix")
Investor presentation
OptiBi otix Health p lc (AI M : OPTI), a life sciences busi ness
d e vel o ping co m p o u n ds to tack le o besit y, high choleste
r ol and diabetes, announces that Stephen O'Hara, Chief Executive,
will be presenting at an investor webinar being hosted jointly by
Turner Pope Investments (TPI) Ltd and Vox Markets.
The event will be held on Thursday, 15 October 2020 at 2pm. To
access the event, please register your interest at
https://voxmarkets.brand.live/c/optibiotix-health-plc-investor-presentation
No new price-sensitive information will be disclosed as part of
the presentation.
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Executive Contact via Walbrook
below
Walbrook PR Ltd Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
About OptiBiotix - www.optibiotix.com
OptiBiotix Health plc (AIM: OPTI), which was formed in March
2012, brings science to the development of compounds which modify
the human microbiome - the collective genome of the microbes in the
body - in order to prevent and manage human disease and promote
wellness.
OptiBiotix has an extensive R&D programme working with
leading academics in the development of microbial strains,
compounds, and formulations which are used as active ingredients
and supplements. More than sixty international food and healthcare
supplement companies have signed agreements with OptiBiotix to
incorporate their human microbiome modulators into a wide range of
food products and drinks.
OptiBiotix is also developing its own range of consumer
supplements and health products. The current areas of focus for the
business include obesity, cardiovascular health, diabetes,
digestive health, and health and wellbeing.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUPGWWUUPUGPB
(END) Dow Jones Newswires
October 09, 2020 09:00 ET (13:00 GMT)
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Sep 2023 to Sep 2024